George R Stark

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.

G. Stark, A. Gudkov, R. Ganapathi, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.

G. Stark, R. Schreiber, C. Ramana, 2002, Trends in immunology.

Regulation of the G2/M transition by p53

G. Stark, W. Taylor, William R Taylor, 2001, Oncogene.

Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways

Tao Lu, Yulong Han, G. Stark, 2007, Proceedings of the National Academy of Sciences.

Analyzing the G2/M checkpoint.

G. Stark, W. Taylor, William R Taylor, 2004, Methods in molecular biology.

NFkappaB-dependent signaling pathways.

G. Stark, Xiaoxia Li, George R Stark, 2002, Experimental hematology.

NF-κB: Regulation by Methylation.

Tao Lu, G. Stark, T. Lu, 2015, Cancer research.

FAM83B mediates EGFR- and RAS-driven oncogenic transformation.

Sarah A. Scott, Rocky Cipriano, G. Stark, 2012, The Journal of clinical investigation.

Complex roles of Stat1 in regulating gene expression

G. Stark, C. Ramana, M. Chatterjee‐Kishore, 2000, Oncogene.

IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage

C. Rice, G. Stark, M. Jackson, 2013, The EMBO journal.